List of Tables
Table 1. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibody Radionuclide Conjugates (ARC)
Table 3. Key Players of Peptide Radionuclide Conjugates (PRC)
Table 4. Key Players of Small Molecular Radionuclide Conjugates (SMRC)
Table 5. Global RDC (Radionuclide Drug Conjugate) Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2019-2024)
Table 9. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2025-2030)
Table 11. RDC (Radionuclide Drug Conjugate) Services Market Trends
Table 12. RDC (Radionuclide Drug Conjugate) Services Market Drivers
Table 13. RDC (Radionuclide Drug Conjugate) Services Market Challenges
Table 14. RDC (Radionuclide Drug Conjugate) Services Market Restraints
Table 15. Global RDC (Radionuclide Drug Conjugate) Services Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players (2019-2024)
Table 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RDC (Radionuclide Drug Conjugate) Services as of 2023)
Table 18. Ranking of Global Top RDC (Radionuclide Drug Conjugate) Services Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Headquarters and Area Served
Table 21. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Product and Application
Table 22. Global Key Players of RDC (Radionuclide Drug Conjugate) Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2019-2024)
Table 26. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Type (2025-2030)
Table 28. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2019-2024)
Table 30. Global RDC (Radionuclide Drug Conjugate) Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global RDC (Radionuclide Drug Conjugate) Services Revenue Market Share by Application (2025-2030)
Table 32. North America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size by Country (2025-2030) & (US$ Million)
Table 47. Rdcthera Company Details
Table 48. Rdcthera Business Overview
Table 49. Rdcthera RDC (Radionuclide Drug Conjugate) Services Product
Table 50. Rdcthera Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
Table 51. Rdcthera Recent Development
Table 52. Abzena Company Details
Table 53. Abzena Business Overview
Table 54. Abzena RDC (Radionuclide Drug Conjugate) Services Product
Table 55. Abzena Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
Table 56. Abzena Recent Development
Table 57. WuXi XDC Company Details
Table 58. WuXi XDC Business Overview
Table 59. WuXi XDC RDC (Radionuclide Drug Conjugate) Services Product
Table 60. WuXi XDC Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
Table 61. WuXi XDC Recent Development
Table 62. CD Formulation Company Details
Table 63. CD Formulation Business Overview
Table 64. CD Formulation RDC (Radionuclide Drug Conjugate) Services Product
Table 65. CD Formulation Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
Table 66. CD Formulation Recent Development
Table 67. CPC Scientific Inc Company Details
Table 68. CPC Scientific Inc Business Overview
Table 69. CPC Scientific Inc RDC (Radionuclide Drug Conjugate) Services Product
Table 70. CPC Scientific Inc Revenue in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024) & (US$ Million)
Table 71. CPC Scientific Inc Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report
List of Figures
Figure 1. RDC (Radionuclide Drug Conjugate) Services Picture
Figure 2. Global RDC (Radionuclide Drug Conjugate) Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Type: 2023 VS 2030
Figure 4. Antibody Radionuclide Conjugates (ARC) Features
Figure 5. Peptide Radionuclide Conjugates (PRC) Features
Figure 6. Small Molecular Radionuclide Conjugates (SMRC) Features
Figure 7. Global RDC (Radionuclide Drug Conjugate) Services Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Medical Device Companies Case Studies
Figure 11. Other Case Studies
Figure 12. RDC (Radionuclide Drug Conjugate) Services Report Years Considered
Figure 13. Global RDC (Radionuclide Drug Conjugate) Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global RDC (Radionuclide Drug Conjugate) Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Region: 2023 VS 2030
Figure 16. Global RDC (Radionuclide Drug Conjugate) Services Market Share by Players in 2023
Figure 17. Global Top RDC (Radionuclide Drug Conjugate) Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RDC (Radionuclide Drug Conjugate) Services as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by RDC (Radionuclide Drug Conjugate) Services Revenue in 2023
Figure 19. North America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
Figure 21. United States RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
Figure 25. Germany RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific RDC (Radionuclide Drug Conjugate) Services Market Share by Region (2019-2030)
Figure 33. China RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
Figure 41. Mexico RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa RDC (Radionuclide Drug Conjugate) Services Market Share by Country (2019-2030)
Figure 45. Turkey RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. UAE RDC (Radionuclide Drug Conjugate) Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Rdcthera Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
Figure 49. Abzena Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
Figure 50. WuXi XDC Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
Figure 51. CD Formulation Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
Figure 52. CPC Scientific Inc Revenue Growth Rate in RDC (Radionuclide Drug Conjugate) Services Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed